Failure of chronic hydroxychloroquine in preventing severe complications of COVID-19 in patients with rheumatic diseases
Concise Report
[키워드] 95% CI
Admission
age
baseline characteristics
clinical presentation
Comorbidities
condition
Control
control subject
control subjects
controls
coronavirus disease
COVID-19
COVID-19 in patient
demographics
diabete
disease
dosages
failure
groups
HCQ
HCQ therapy
hospital
Hospitalization
hospitalized patient
Hydroxychloroquine
in-hospital mortality
individual
IQR
less
Logistic regression
Lupus
mechanical ventilation
median age
medications
New York City
obesity
objective
outcome
Patient
pre-exposure prophylaxis
Prednisone
Prevalence
preventive
proportion
pulmonary disease
receive
receiving
reported
Result
rheumatic disease
rheumatoid arthritis
rheumatologic diseases
severe complication
statistically significant difference
subject
with COVID-19
[DOI] 10.1093/rap/rkab014 PMC 바로가기 [Article Type] Concise Report
[DOI] 10.1093/rap/rkab014 PMC 바로가기 [Article Type] Concise Report